Erin Moshier

7PUBLICATIONS
60CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical mycologyOther health sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2025
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy.

Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar

|Feb 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.

Bruno Almeida Costa, Danai Dima, Tomer Mark

|Sep 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.

Santiago Thibaud, Ryan L Subaran, Scott Newman

|Jan 22, 2024
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic.

Julie R Bloom, Carlos Rodriguez-Russo, Kristin Hsieh

|Sep 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.

Urvi A Shah, Erin Moshier, Andriy Derkach

|Sep 28, 2021
PD-1 inhibition in advanced myeloproliferative neoplasms.

Gabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier

Pageof 2

Frequent Collaborators

3 joint publications

Sundar Jagannath

3 joint publications

Adriana Rossi

3 joint publications

Samir Parekh

3 joint publications

Hearn Jay Cho